Acquiring Company
Pfizer
Acquired Company
Metsera
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsBiotechnologyHealth CareDescription
Pfizer is nearing a $7.3 billion takeover of anti-obesity drug developer Metsera. The deal marks Pfizer's first major acquisition in two years, aimed at expanding its presence in the weight-loss drug market. Metsera's innovative treatments, which show promise in body mass reduction, align with Pfizer's strategic goals following the setbacks of its own experimental drug.
Quick answer
Pfizer is acquiring Metsera for $7.3 billion, announced September 22, 2025. Pfizer is based in New York, New York, United States.
- How much did Pfizer pay for Metsera?
- The reported deal value is $7.3 billion.
- Where are Pfizer and Metsera based?
- Pfizer is based in New York, New York, United States.
- Who are the decision-makers at Pfizer?
- Fundz holds 2 contacts at Pfizer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Pfizer secures clearance for Metsera acquisition (October 31, 2025)
- Pfizer acquires Metsera for $7.3 billion, $7.3B (October 13, 2025)
- AbbVie completes acquisition of Capstan Therapeutics (August 19, 2025)
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- Novartis to acquire Tourmaline Bio in tender offer (October 22, 2025)
- Pfizer acquires Seagen for $43 billion, $43B (October 3, 2025)
Who to call at Pfizer, and when
When Pfizer changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Metsera?
Metsera was acquired by Pfizer, based in New York. The deal was reported on September 22, 2025. Pfizer is publicly traded (PFE) and operates in Biotechnology.
When did Pfizer acquire Metsera?
Pfizer's acquisition of Metsera was reported on September 22, 2025. Pfizer is nearing a $7.3 billion takeover of anti-obesity drug developer Metsera. The deal marks Pfizer's first major acquisition in two years, aimed at expanding its presence in the weight-loss drug market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Metsera do?
Metsera is a weight-loss drug developer founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.